LifeMD, Inc. - SIC # 8081 -

Ticker Exchange SIC # Website Latest Ticker
LFMD Nasdaq 8081 lifemd.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for LifeMD, Inc.

GLP-1 Users Turn to Telehealth to Access Weight Loss Drugs - May 18th, 2026 2:23 pm
LifeMD to Participate in Upcoming Investor Conferences - May 15th, 2026 6:00 am
LifeMD, Inc. Q1 2026 Earnings Call Summary - May 7th, 2026 6:30 am
LifeMD Q1 Earnings Call Highlights - May 6th, 2026 8:16 pm
LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates - May 6th, 2026 4:30 pm
LifeMD (LFMD) Q1 2026 Earnings Transcript - May 6th, 2026 4:16 pm
LifeMD Reports First Quarter 2026 Results - May 6th, 2026 2:05 pm
Medifast Q1 Earnings Call Highlights - May 4th, 2026 7:10 pm
How The LifeMD (LFMD) Story Is Shifting Around GLP-1 Growth And 2026 Expectations - May 2nd, 2026 1:18 pm
LifeMD to Report First Quarter 2026 Financial Results on May 6 - Apr 27th, 2026 6:00 am
LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock? - Apr 21st, 2026 6:00 am
How The LifeMD (LFMD) Story Is Shifting Around GLP-1 Growth Plans And 2026 Expectations - Apr 17th, 2026 11:05 am
Oramed Pharmaceuticals And Two Other Promising Penny Stocks For Savvy Investors - Apr 14th, 2026 12:06 pm
Hims & Hers Powers Patient-Provider Connectivity via Digital Platforms - Apr 14th, 2026 7:49 am
LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management - Apr 10th, 2026 6:15 am
Novo launches $249 Wegovy subscription, undercutting Lilly as shares fall 30% - Mar 31st, 2026 3:23 pm
Novo Nordisk launches Wegovy subscription program - Mar 31st, 2026 7:15 am
LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program - Mar 31st, 2026 6:45 am
Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year - Mar 31st, 2026 5:46 am
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - Mar 24th, 2026 2:05 pm